Taiwan Clinical Trial Results of 2cPA to Be Presented at OARSI 2024

February 21, 2024

At the 2024 OARSI World Congress on Osteoarthritis, held from April 18 to 21, 

2024 in Vienna, Austria, the clinical trial results from Taiwan on 

2-carba cyclic phosphatidic acid (2ccPA; synthetic compound, drug candidate) 

for osteoarthritis will be presented in a poster session.

The presentation will be delivered by Dr. Ikuko Masuda, SAB member of our company,

and Head of Rheumatology and Orthopedics at Jujo Takeda Rehabilitation Hospital

/ Visiting Lecturer at Tokyo Women’s Medical University.